The 2014 Farm Bill, legalized the sale of "non-viable hemp material" grown within states participating in the Hemp Pilot Program. This legislation defined hemp as cannabis containing less than 0.3% of THC delta-9, grown within the regulatory framework of the Hemp Pilot Program. This has led many to insist that CBD manufactured from hemp, is legal in all 50 states and exempts its oversight by the DEA as a controlled substance. The 2018 Farm Bill is anticipated to provide further clarity regarding hemp regulations.
A non-intoxicating, highly therapeutic compound in cannabis known as CBD, or cannabidiol, has sparked a revolution in cannabis. Studies have demonstrated CBD’s benefits in treating a variety of ailments, including epilepsy, cancer, pain, arthritis, and anxiety disorders, although it can also be used to alleviate everyday stress and more mild symptoms.
Cannabidiol is currently a class B1 controlled drug in New Zealand under the Misuse of Drugs Act. It is also a prescription medicine under the Medicines Act. In 2017 the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health.